BET inhibition reveals glycolytic vulnerability via HIF1α in triple-negative breast cancer
In a groundbreaking study poised to reshape the therapeutic landscape of aggressive breast cancers, researchers have uncovered a novel metabolic ...
In a groundbreaking study poised to reshape the therapeutic landscape of aggressive breast cancers, researchers have uncovered a novel metabolic ...
The intricate interplay between epigenetic modifications and metabolic pathways has recently emerged as a pivotal area of research in cancer ...
In a groundbreaking study published in Cell Death Discovery, a team of researchers led by Wang, K., Xiao, Y., and ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine